Executive Order Category Rationale

Justification

This executive order's primary subject matter is the domestic production of pharmaceutical products and medicines to ensure American patients have access to critical medications. The order explicitly states its purpose is to address "Critical barriers and information gaps persist in establishing a domestic, resilient, and affordable pharmaceutical supply chain for American patients" and makes "the well-being of the American people" through access to medicines its central concern. While the order uses regulatory streamlining as its mechanism, the fundamental target is the pharmaceutical manufacturing sector and drug supply chain, with the stated goal of making medicines more available to Americans. The order comprehensively addresses FDA pharmaceutical inspections, drug manufacturing facility approvals, and the entire supply chain for "Essential Medicines, Medical Countermeasures, and Critical Inputs," which are core public health and healthcare infrastructure concerns.

Secondary relevant categories

• Regulatory Reform & Oversight
• National Security & Intelligence